Progressive Multiple Sclerosis Completed Phase 2 / 3 Trials for Glatiramer (DB05259)

Also known as: Progressive multiple sclerosis

IndicationStatusPhase
DBCOND0051688 (Progressive Multiple Sclerosis)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03315923Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis PatientsTreatment